drugset / Trial / NCT06304909

Effect of Intravenous Dexmedetomidine Versus Dexamethasone for Management of Repound Pain After Supraclavicular Brachial Plexus Block

NCT06304909

Phase 1 Completed 111 enrolled Assiut University
RandomizedCrossoverSingle-blindTreatment

Summary

Effect of intravenous dexmedetomidine versus dexamethasone for management of repound pain after supraclavicular brachial plexus block.

Timeline

Start
2024-05-15
Primary completion
2025-03-10
Completion
2025-03-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 8 mg/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous

Indications

No indication recorded.